PRF Technologies Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. It offers PRF-110, an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized and extended post-operative analgesia. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
7
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. PRF Technologies Ltd. market cap is $2.01M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. PRF Technologies Ltd. 52 week high is $7.95 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. PRF Technologies Ltd. 52 week low is $0.641 as of November 18, 2026.
PRF Technologies Ltd. stock price today is $0.6292.
PRF Technologies Ltd. stock price yesterday was $0.661.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. PRF Technologies Ltd.'s P/E ratio is -0.13.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. PRF Technologies Ltd. P/B ratio is 0.1267.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. PRF Technologies Ltd. 50-day moving average is $0.8438.